Patent & IP news for December 8, 2013

Cape Town Conference Highlights Innovation, IP And Public Interest from www.ip-watch.org

CAPE TOWN, SOUTH AFRICA – Some 350 experts from around the world are gathering here this week to discuss intellectual property rights and innovation as they relate to the public interest.Related Articles:

• “Washington Declaration” Demands ...

Share via E–mail | Twitter | Facebook

Momentum Events "IP Counsel Exchange for Biosimilar Applicants and Sponsors," New York, January 23-24 from www.orangebookblog.com

Momentum Event Group will be holding its inaugural "IP Counsel Exchange for Biosimilar Applicants and Sponsors" January 23-24 in New York City. The effect of the recent Sandoz v. Amgen decision on biosimilar patent litigation ...

Share via E–mail | Twitter | Facebook

BCP Customer Partnership Meeting from www.patentdocs.org

The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on Monday, December 9, 2013. The agenda for the meeting is as follows: Morning Session • Meet ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from www.patentdocs.org

December 9, 2013 - Biotechnology/Chemical/Pharmaceutical (BCP) customer partnership meeting (U.S. Patent and Trademark Office) - 9:00 am to 2:45 pm (ET) December 9-10, 2013 - Patent Infringement Litigation Summit (Legal iQ (IQPC)) - San ...

Share via E–mail | Twitter | Facebook

Court Report from www.patentdocs.org

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Astrazeneca AB et al. v. Aurobindo Pharma Ltd. et al. 3:13-cv-07298; filed December 3, 2013 ...

Share via E–mail | Twitter | Facebook